Speakers and Faculty


The 2019 NYC Neuromodulation Conference and Neuromodulation: The Science bring together leaders across neuromodulation, pain management, healthcare, and wearables. This unparalleled collection of thought leaders supports an engaging program spanning three days (October 4-6, 2019) with an additional one day of Preconference Workshops (October 3, 2019). See all speakers >>

Marian Berryhill, PhD

Marian Berryhill, PhD

In the Memory and Brain Lab, Marian Berryhill investigates the neural correlates of various forms of memory. Experimental approaches including neuroimaging (fMRI, HD-EEG, fNIRS), neurostimulation (tDCS, HD-tDCS), behavioral and neuropsychological patients.


Interview with Marian Berryhill, PhD

What are you most excited about (or looking forward to) at NTS/NYN Napa?

MB: I’m looking forward to hearing from my colleagues. We all benefit by getting together and hearing what others are working on. Let’s hope they can help us solve problems and that we can provide insight on others’ problems as well.

The success of neurotechnology is often throttled by understanding of the underlying science. Where do you see the most important area of research or recent breakthroughs in the science underling brain interfacing technology?

MB: The full mechanism of action is a true gap in our understanding with regard to neurostimulation. I hope that the conference will succeed in bringing people together across scales of inquiry: across pharmacological responses, animal models, neuropsychological patients, and neurotypicals.

Describe the more formative experiences in your education or training that informed your current research? Were there specific technologies, ideas, or applications that inspired you?

MB: My graduate training provided training in TMS, and my postdoctoral experience introduced me to tDCS. This training was invaluable going forward for me. Over the last decade, my lab has used tDCS/tACS to benefit executive function in young and older adults, while also making progress in understanding the underlying mechanism by which lasting changes can occur.

As chair of session 8, what are your goals?

MB: My goals for the session are to hear from my esteemed colleagues and to try to convey some of our own progress and challenges. We have a series of excellent speakers with a wide array of topics and areas of research. In particular, it will be really intriguing to see how gastric disorders (Dr. Chen) respond to neurostimulation. In addition, I look forward to learning about neural photobiomodulation from Dr. Liu. It will be valuable to get out of our own local concerns and think more broadly about application, translation, and progress as a field.